Daiwa Securities Group Inc. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%690.0%0.00%
Q2 2023$1
-66.7%
690.0%0.00%
Q1 2023$30.0%690.0%0.00%
Q4 2022$3
-99.9%
690.0%0.00%
Q3 2022$4,000
+33.3%
690.0%0.00%
Q2 2022$3,000
-40.0%
690.0%0.00%
Q1 2022$5,0000.0%690.0%0.00%
Q4 2021$5,000
+25.0%
690.0%0.00%
Q3 2021$4,000
+100.0%
69
+81.6%
0.00%
Q2 2021$2,0000.0%380.0%0.00%
Q1 2021$2,0000.0%380.0%0.00%
Q4 2020$2,000
-60.0%
38
-65.8%
0.00%
Q3 2020$5,000
-16.7%
1110.0%0.00%
Q2 2020$6,0000.0%1110.0%0.00%
Q1 2020$6,000
-14.3%
1110.0%0.00%
Q4 2019$7,0000.0%111
-10.5%
0.00%
Q3 2019$7,000
-30.0%
1240.0%0.00%
Q2 2019$10,000
-16.7%
1240.0%0.00%
Q1 2019$12,000
+71.4%
124
+18.1%
0.00%
Q4 2018$7,000
-22.2%
1050.0%0.00%
Q3 2018$9,000
-25.0%
1050.0%0.00%
Q2 2018$12,000
+50.0%
1050.0%0.00%
Q1 2018$8,0001050.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 511,186$43,686,00011.23%
GREAT POINT PARTNERS LLC 210,400$17,981,0002.80%
ARMISTICE CAPITAL, LLC 456,000$38,970,0002.34%
Matarin Capital Management, LLC 210,208$17,964,376,0001.16%
Sapphire Star Partners LP 8,168$698,0000.70%
Granahan Investment Management 103,320$8,830,0000.48%
FARALLON CAPITAL MANAGEMENT LLC 867,500$74,137,0000.44%
361 CAPITAL LLC 19,040$1,627,0000.35%
ALGERT GLOBAL LLC 17,922$1,532,0000.33%
AlphaMark Advisors, LLC 9,310$796,0000.32%
View complete list of ENANTA PHARMACEUTICALS INC shareholders